{"id":"NCT03764007","sponsor":"Thomas Hope","briefTitle":"18F-Fluorocholine for the Detection of Parathyroid Adenomas","officialTitle":"18F-Fluorocholine for the Detection of Parathyroid Adenomas","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2016-09-21","primaryCompletion":"2021-05-31","completion":"2021-05-31","firstPosted":"2018-12-04","resultsPosted":"2021-10-19","lastUpdate":"2021-10-19"},"enrollment":98,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Hyperparathyroidism, Primary"],"interventions":[{"type":"DRUG","name":"18F-Fluorocholine","otherNames":["Fluorocholine"]},{"type":"PROCEDURE","name":"Positron Emission Tomography (PET)","otherNames":["PET"]}],"arms":[{"label":"18F-Fluorocholine PET","type":"EXPERIMENTAL"}],"summary":"The investigators are studying the ability of F18 labeled fluorocholine PET to localize parathyroid adenomas in patients with hyperparathyroidism prior to surgery.","primaryOutcome":{"measure":"Proportion of True Positives for the Overall Detection of the Abnormal Parathyroid Adenoma","timeFrame":"Up to 1 year","effectByArm":[{"arm":"18F-Fluorocholine PET","deltaMin":0.75,"sd":null}],"pValues":[]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":98},"commonTop":[]}}